Single arm, open label, signal seeking, phase IIa trial of the activity of vismodegib in patients with tumours harbouring PTCH1 or SMO mutations
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 29 May 2018
At a glance
- Drugs Vismodegib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 24 May 2018 Planned initiation date changed from 1 Jun 2018 to 1 Sep 2018.
- 23 Feb 2018 New trial record
- 22 Feb 2018 According to an Australian New Zealand Clinical Trials Registry record, the anticipated date of last participant enrolment is 1 Jun 2020.